ENTITY

Exact Sciences (EXAS US)

38
Analysis
Health CareUnited States
Exact Sciences Corp., is focused on developing and commercializing a non-invasive molecular screening test for the early detection and prevention of colorectal cancer. The Company's test is a stool-based DNA test that identifies both pre-cancer and cancer by detecting genetic mutations in colorectal cancer cells.
more
26 Nov 2020 21:49
Smartkarma Originals

Asian Healthcare - Coming of Age

This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...

Share
26 Nov 2020 13:59

New Horizon Health (诺辉健康) Pre-IPO: A Hot Medical Device Deal in Making

The company's product has a huge unmet market and a high barrier to entry. We believe its uniqueness as the only investable stock in the segment...

Logo
803 Views
Share
bullishS&P 500 INDEX
22 Jul 2020 21:34

U.S. Equity Strategy: Bullish Outlook Intact

With the S&P 500 breaking above the June highs and the Russell 2000 bullishly inflecting topside a ~1-month base, it signals a continuation of...

Logo
392 Views
Share
08 Jun 2020 14:49

Burning Rock (传奇生物) IPO: Sentiment Matters

Burning Rock, a leading precision oncology player in China, started book building to raise up to USD 235 million (including concurrent private...

Logo
344 Views
Share
04 Jun 2020 11:17

Burning Rock (燃石医学) Pre-IPO: Thoughts on Valuation

Burning Rock, a leading precision oncology player in China, is aiming to raise USD 100 million via a listing in the US. The company is the number...

Logo
497 Views
Share
x